Several effector subsets of CD4 T cells have been identified as potent regulators of AD pathogenesis, including TH1, TH2, TH17, and TREG cells (Grewe et al., 1998; Martel et al., 2016). This evidence concerns the gene CD4 and Alzheimer disease.